Exatecan (DX-8951f), a new topoisomerase I - inhibitor, is inactive in heavily pretreated patients (pts.) with advanced soft tissue sarcoma (STS): A phase II - study of the EORTC Soft Tissue and Bone Sarcoma Group

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 9058-9058
Author(s):  
D. Pink ◽  
P. Reichardt ◽  
O. S. Nielsen ◽  
S. Bauer ◽  
J. T. Hartmann ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase Ii ◽  
Topoisomerase I ◽  
Phase Ii Study ◽  
Bone Sarcoma ◽  
Advanced Soft Tissue Sarcoma ◽  
Topoisomerase I Inhibitor ◽  
Heavily Pretreated ◽  
Pretreated Patients

VP-16 in advanced soft tissue sarcoma: A phase II study of the EORTC soft tissue and bone sarcoma group

1987 ◽  
Vol 23 (5) ◽  
pp. 579-580 ◽  
Author(s):  
P. Dombernowsky ◽  
J. Buesa ◽  
H.M. Pinedo ◽  
A. Santoro ◽  
H. Mouridsen ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Bone Sarcoma ◽  
Advanced Soft Tissue Sarcoma

Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group

1992 ◽  
Vol 28 (4-5) ◽  
pp. 855-857 ◽  
Author(s):  
R. Somers ◽  
A. Santoro ◽  
J. Verweij ◽  
P. Lucas ◽  
J. Rouëssé ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Bone Sarcoma ◽  
Advanced Soft Tissue Sarcoma

Oral piritrexim ? A phase II study in patients with advanced soft tissue sarcoma

1992 ◽  
Vol 10 (2) ◽  
pp. 97-98 ◽  
Author(s):  
Judith D. Schiesel ◽  
Matthew Carabasi ◽  
Gordon Magill ◽  
Ephraim Casper ◽  
Edgar Cheng ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Soft Tissue Sarcoma
Sign in / Sign up

Export Citation Format

Share Document